However, MAO-B inhibitors such as selegiline have also been shown to improve depression in PD26,27 and, at high doses, they are nonselective, additionally affecting serotonergic transmission, which may represent a complementary pathway to improving mood25,28. The gene discussed is MAOB; the disease is depressive symptom measurement.